Home  /  Resource Library  /  The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab

The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab

Study examined the effect of complex karyotype abnormalities on overall survival in CLL patients treated with Idelalisib.